Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,525.00
+22.50 (0.90%)
Nov 11, 2026, 1:15 PM IST
Caplin Point Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 191,818 | 114,409 | 152,221 | 100,038 | 45,291 | 51,529 | |
Market Cap Growth | 30.64% | -24.84% | 52.16% | 120.88% | -12.11% | 68.55% |
Enterprise Value | 182,987 | 105,432 | 145,046 | 94,232 | 40,317 | 46,183 |
Last Close Price | 2502.50 | 1499.51 | 1987.34 | 1302.94 | 587.40 | 664.89 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 28.93 | 17.84 | 28.38 | 21.89 | 12.04 | 17.18 |
PS Ratio | 8.31 | 5.23 | 7.85 | 5.90 | 3.09 | 4.05 |
PB Ratio | 5.24 | 3.15 | 5.27 | 4.26 | 2.38 | 3.41 |
P/TBV Ratio | 5.50 | 3.45 | 5.81 | 4.79 | 2.74 | 4.10 |
P/FCF Ratio | 69.10 | 41.59 | 63.20 | 57.97 | 58.14 | 20.99 |
P/OCF Ratio | 36.33 | 21.87 | 35.21 | 31.42 | 16.69 | 15.30 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.93 | 4.82 | 7.48 | 5.56 | 2.75 | 3.63 |
EV/EBITDA Ratio | 22.83 | 13.83 | 22.36 | 17.11 | 9.16 | 11.73 |
EV/EBIT Ratio | 25.23 | 15.18 | 24.71 | 18.81 | 10.12 | 13.21 |
EV/FCF Ratio | 65.89 | 38.32 | 60.22 | 54.61 | 51.75 | 18.81 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
Debt / FCF Ratio | - | 0.02 | 0.02 | 0.01 | 0.07 | 0.01 |
Net Debt / Equity Ratio | -0.28 | -0.25 | -0.30 | -0.31 | -0.34 | -0.34 |
Net Debt / EBITDA Ratio | -1.26 | -1.19 | -1.36 | -1.33 | -1.47 | -1.30 |
Net Debt / FCF Ratio | - | -3.29 | -3.65 | -4.25 | -8.28 | -2.08 |
Asset Turnover | - | 0.60 | 0.66 | 0.69 | 0.75 | 0.82 |
Inventory Turnover | - | 2.36 | 2.29 | 2.32 | 2.64 | 2.82 |
Quick Ratio | - | 4.74 | 5.19 | 4.01 | 3.99 | 4.08 |
Current Ratio | - | 6.70 | 6.97 | 5.72 | 5.79 | 6.25 |
Return on Equity (ROE) | - | 19.94% | 20.68% | 21.69% | 22.06% | 22.74% |
Return on Assets (ROA) | - | 11.97% | 12.42% | 12.81% | 12.68% | 14.10% |
Return on Invested Capital (ROIC) | 21.57% | 23.76% | 25.93% | 28.47% | 29.42% | 31.50% |
Return on Capital Employed (ROCE) | - | 19.00% | 20.20% | 21.20% | 20.70% | 22.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.46% | 5.61% | 3.52% | 4.57% | 8.31% | 5.82% |
FCF Yield | 1.45% | 2.40% | 1.58% | 1.73% | 1.72% | 4.76% |
Dividend Yield | 0.32% | 0.53% | 0.30% | 0.38% | 0.75% | 0.59% |
Payout Ratio | 9.16% | 7.11% | 7.08% | 7.48% | 8.06% | 7.57% |
Buyback Yield / Dilution | 0.14% | 0.14% | -0.05% | 0.26% | -0.18% | -0.07% |
Total Shareholder Return | 0.46% | 0.67% | 0.25% | 0.64% | 0.58% | 0.52% |